Business description: AbbVie Inc.

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease.

Net sales are distributed geographically as follows: the United States (76.4%), Germany (2.6%), Japan (2%), Canada (1.9%), China (1.6%), France (1.4%), Spain (1%), the United Kingdom (0.9%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and other (9.7%).

Number of employees: 55,000

Sales by Activity: AbbVie Inc.

Fiscal Period: December20202021202220232024

Innovative Medicines and Therapies

45.8B 56.2B 58.05B 54.32B 56.33B
See all business segments

Geographical breakdown of sales: AbbVie Inc.

Fiscal Period: December20202021202220232024

United States

34.88B 43.51B 45.71B 41.88B 43.03B

ALL Other Countries

3.98B 4.76B 4.84B 5.04B 5.45B

Germany

1.05B 1.22B 1.34B 1.27B 1.46B

Japan

1.2B 1.09B 956M 1.01B 1.12B

Canada

1.16B 1.4B 1.16B 1.08B 1.09B

China

471M 857M 912M 950M 917M

France

797M 936M 787M 780M 776M

Spain

453M 519M 506M 501M 528M

United Kingdom

509M 497M 462M 417M 522M

Italy

379M 506M 444M 484M 511M

Brazil

406M 368M 430M 439M 464M

Australia

527M 533M 508M 472M 463M
See all geographic segments

Executive Committee: AbbVie Inc.

Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 58 2022-06-22
Chief Tech/Sci/R&D Officer - 2002-12-31
Chief Operating Officer 61 2023-06-30
Investor Relations Contact - 2012-12-31
See ABBVIE INC. governance

Composition of the Board of Directors: AbbVie Inc.

Director TitleAgeSince
Director/Board Member 64 2012-12-31
Director/Board Member 73 2012-12-31
Director/Board Member 67 2012-12-31
Chairman 54 2025-06-30
Director/Board Member 72 2017-12-31
Director/Board Member 70 2020-05-07
Director/Board Member 74 2012-12-31
Director/Board Member 55 2015-12-31
Director/Board Member 67 2016-12-31
Director/Board Member 71 2012-12-31
Composition of the Board of Directors

Shareholders: AbbVie Inc.

NameEquities%Valuation
The Vanguard Group, Inc.
10.04 %
177,266,703 10.04 % 32 904 M $
Vanguard Fiduciary Trust Co.
9.852 %
173,917,865 9.852 % 32 283 M $
BlackRock Advisors LLC
6.222 %
109,845,548 6.222 % 20 390 M $
4.53 %
79,962,967 4.53 % 14 843 M $
JPMorgan Investment Management, Inc.
3.111 %
54,927,926 3.111 % 10 196 M $
NameEquities%Valuation
Caixa DTVM SA
0.0219 %
386,422 0.0219 % 4 M $
BRAM - Bradesco Asset Management SA DTVM
0.003123 %
55,128 0.003123 % 640 383 $
List of ABBVIE INC. shareholders

Holdings: AbbVie Inc.

NameEquities%Valuation
4,347,826 9.5% 2,956,522 $
1,855,871 4.45% 723,790 $

Company details: AbbVie Inc.

AbbVie, Inc.

1 North Waukegan Road

60064-6400, North Chicago

+847 932 7900

http://www.abbvie.com
address AbbVie Inc.(ABBV)

Group companies: AbbVie Inc.

NameCategory and Sector
AbbVie Biopharmaceuticals GmbH Taiwan Branch
Pharmaceuticals: Major
Pharmaceuticals: Major
Medical Distributors
AbbVie Finance BV
Pharmaceuticals: Major
See all subsidiaries

Other Pharmaceuticals

Change 5d. change 1-year change 3-years change Capi.($)
+0.00%-0.60%+12.83%+23.74% 335B
+0.98%+0.82%-15.75%+137.31% 698B
-0.14%-0.05%+5.74%-12.82% 375B
-1.53%+0.35%-54.14%+9.26% 313B
+0.89%-0.04%+6.30%-20.36% 259B
-0.16%-0.89%+0.47%+17.53% 240B
+0.21%-0.27%-13.25%-7.10% 217B
+3.05%+1.59%-33.59%-11.24% 204B
-0.67%-0.70%-6.69%+18.97% 160B
-0.72%+0.28%-8.41%-51.99% 146B
Average +0.16%+0.74%-10.65%+10.33% 294.8B
Weighted average by Cap. +0.25%+0.50%-10.79%+31.36%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
189.77USD
Average target price
209.12USD
Spread / Average Target
+10.20%
Consensus

Quarterly revenue - Rate of surprise